Back to search

National and Kapodistrian University of Athens

Ανίχνευση, χαρακτηρισμός και λειτουργική μελέτη μεταλλαγών σε ογκοκατασταλτικά και επιδιορθωτικά γονίδια που σχετίζονται με την καρκινογένεση

Abstract

dc:description

Hereditary cancer accounts for a small percentage of cancer incidents and is characterized by cancer development at young age and the presence of multiple cases of related malignancies among family members. Breast cancer is the most common malignancy and the leading cause of the death among women in developed and developing countries. Approximately 30% of breast cancer cases present family history with at least two relatives diagnosed with cancer (familial cases), while in 5-10% a mutation in a susceptibility gene has been identified. Hereditary breast cancer is related to germline mutations in BRCA1 and BRCA2 genes. Both genes play key roles in homologous recombination, a very important repair pathway of DNA double strand breaks. The lifetime breast cancer risk is 57-65% for BRCA1 and 35-57% for BRCA2 mutation carriers. Over the last years, the use of Next Generation Sequencing (NGS) highlighted new susceptibility breast cancer genes, such as PALB2, ATM and CHEK2. All the above genes are also participate in homologous recombination.Apart from the mentioned genes, mismatch repair genes (MMR) are known cancer susceptibility genes (MLH1, MSH2, MSH6 και PMS2). Germline mutations in MMR genes are associated with ovarian cancer development, one of the main characteristics of Lynch syndrome, among other malignancies. Identification of germline mutations of cancer predisposing genes explains a percentage of diagnosed incidents. However, there is still a significant proportion of familial cases in which the genetic background of cancer development remains unidentified. This is a trigger for the investigation of alternative mechanisms that may be involved in carcinogenesis, such as epigenetic alterations and specifically methylation. Changes of methylation patterns is associated with cancer development through gene expression modifications inducing genetic instability. The aim of the dissertation was to investigate the genetic background of Greek breast,ovarian and Lynch syndrome patients using different approaches/techniques in order to identify new susceptibility genes and characterize new mutations that are associated with various types of cancer. At the same time, epigenetic silencing through hypermerthylation of genes that possibly participate on cancer development was investigated on patients whose hereditary background remained undefined. Originally, 172 breast cancer patients were analyzed for the identification of pathogenic variants on BRCA genes by Sanger sequencing. The analysis revealed 12.2% BRCA1 and 5.2% BRCA2 mutation carriers. The patients that carried no point mutation were further analyzed by MLPA for the detection of Large Genomic Rearrangements (LGRs) on these genes and no carriers were identified. In order to determine the prevalence of BRCA LGRs on Greek patients, the MLPA analysis was expanded in 443 additional breast cancer patients. This analysis revealed two deletions (0.5%), one on BRCA1 gene (deletion of exons 1-2) and one on BRCA2 gene (deletion of exons 12-13). The latter LGR is quite common for people of Greek ancestry. Furthermore, NGS was employed on breast cancer patients (108) that were not BRCA mutation carriers and presented extremely severe family history. «TruSight Cancer Panel» that includes 94 cancer susceptibility genes, was used and seventeen (17/108, 15.7%) mutations on known and less known cancer susceptibility genes, were identified. Specifically, five PALB2, four CHEK2, two RAD51C, two TP53 and one on ALK and FANCM variants were detected. ATM and CHEK2 are known predisposing breast cancer genes, while PALB2 has been recently identified as a high penetrant gene. RAD51C is identified as a susceptibility gene to ovarian cancer, although late studies have shown that is possible certain variants to influence breast cancer development as well. This hypothesis is in accordance with the results of the present work. Finally, FANCM gene quite recently has been associated with breast cancer predisposition, whose mutations are rare, as it is supported in the present study. Next Generation Sequencing revealed a recurrent PALB2 mutation c.2257C>T. So, we aimed to clarify its possible founder effect on Greek population as well as to investigate correlations with cancer diagnosis. Genotyping for the mutation was performed on 2496 breast and 697 ovarian cancer patients and identified 6 (0.24%) and 1 (0.14%) carriers, respectively, while haplotype analysis performed on all mutation carriers. Haplotype analysis was conducted using seven microsatellite markers (one intragenic and 6 extragenic) and all carriers shared a 1.2 Mb common haplotype “157-228-127-166-263” indicating that this variant came from a single recombination event in a common ancestor 1600 years ago.In addition, as mentioned above, germline mutations on MMR genes are associated with hereditary cancer. Thus, 93 probands selected according to their personal (early onset diagnosis) and/or family history (presence of Lynch syndrome related malignancies) were analyzed in order to determine the mutation spectra of MMR genes on Greek patients. Point mutations or small insertions/deletions were detected in 29/93 and specifically mutations in MLH1 and MSH2 were predominantly identified (25.8%), while the proportion of MSH6 and PMS2 was significantly lower, 4.3% and 1.1% respectively. As a next step, MLPA was employed on non-mutation carriers for the detection of LGRs on MLH1 and MSH2 genes which represent the majority of the rearrangements that have been described on MMR genes. Genomic rearrangements identified on MSH2 exclusively (8/93, 8.6%) involving deletions of exons 1-6, 1-7, 1-8, 3-4, 9-10 and 7-16, indicating that such phenomena are possibly frequent in patients of Greek descent. Finally, 1-6, 3-4, 9-10 and 7-16 break points were determined. Furthermore, NGS analysis pointed out a proportion of patients that carry no mutation on breast cancer predisposing genes. This observation lead us to investigate the promoter methylation status of 22 genes, related to different repair pathways, of patients diagnosed at early age and triple negative tumors. The results compared to BRCA1 mutation-carriers patients with corresponding diagnoses. This analysis revealed 5 genes with hypermethylated promoters (methylation percentage> 30%), CDH1, HIC1, PYCARD, RASSF1 and TP73, demonstrating a possible correlation of epigenetic silencing of these genes with disease development.Overall, the present dissertation revealed the genetic diversity of the Greek population which at the same time is characterized by strong founder effects in terms of hereditary cancer and in particular hereditary breast and ovarian cancer. In addition, the contribution of epigenetic silencing, hypermethylation, of specific genes that are involved in crucial for carcinogenesis signaling pathways was shown. Clarification and understanding of genetic background and mechanisms that contribute in carcinogenesis is very important in order to provide patients and their family members appropriate clinical management.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vagena, Andromachi
  • Βαγενά, Ανδρομάχη

Subjects

dc:subject × 6

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45895

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vagena, Andromachi; Βαγενά, Ανδρομάχη. Ανίχνευση, χαρακτηρισμός και λειτουργική μελέτη μεταλλαγών σε ογκοκατασταλτικά και επιδιορθωτικά γονίδια που σχετίζονται με την καρκινογένεση. National and Kapodistrian University of Athens, 2019. http://hdl.handle.net/10442/hedi/45895